NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Cocer Peptides? Mail in a sample (US only) and let us test it.

Test my supply
60%
Finnrick rating
#306 of 344 ranked vendors
5 of 9 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Cocer Peptides has a narrow, current purity-focus record led by cleaner Retatrutide passes, but the evidence is dispersed rather than steady. Retatrutide later swings to an identity/purity failure after a major overfill, while Tesamorelin's weak points are repeated large overfills; limited volume keeps uncertainty high.

methodology →
vendor intelligence report
Vendor Intelligence Report: Cocer Peptides

WHOIS and domain evidence test Cocer’s experience claims while mapping a fragmented brand surface, including a confirmed .top impersonation and a shifting .net storefront. The report also traces self-submitted COAs, fake-tracking complaints, and weak recourse rails.

20 pages8 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$1.70
74%
5
2
Tesamorelin
$1.60
46%
4
3
BPC-157
$0.75
-
0
4
GHK-Cu
$0.11
-
0
5
Ipamorelin
$1.00
-
0
6
TB-500
$1.80
-
0
7
Tirzepatide
$1.80
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%21 Oct 2025: 76%11 Dec 2025: 53%15 Jan 2026: 52%4 Feb 2026: 54%4 Feb 2026: 54%12 Mar 2026: 60%12 Mar 2026: 61%8 Jun 2026: 62%16 Jun 2026: 61%18 Sept 2026: current 60%76%60%60%Oct 25Sep 26
Cocer Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
16 Jun 2026
Fail
Retatrutide
lab nameView COA
8 Jun 2026
Fail
Tesamorelin
lab nameView COA
12 Mar 2026
Pass
Tesamorelin
lab nameView COA
12 Mar 2026
Pass
Retatrutide
lab nameView COA
4 Feb 2026
Pass
Retatrutide
lab nameView COA
4 Feb 2026
Fail
Tesamorelin
lab nameView COA
15 Jan 2026
Fail
Retatrutide
lab nameView COA
11 Dec 2025
Pass
Tesamorelin
lab nameView COA
21 Oct 2025
Pass
Retatrutide
lab nameView COA

About Cocer Peptides test results from Finnrick

Cocer Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 9 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Cocer Peptides peptides in this dataset are Retatrutide (5 tests), Tesamorelin (4 tests) and BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 9 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Cocer Peptides? Mail in a sample (US only) and let us test it.

Test my supply